Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials.

被引：0
|
作者：
Brunner, Hermine I. [1 ]
Ruperto, Nicolino [2 ]
Quartier, Pierre [3 ]
Constantin, Tamas [2 ]
Wulffraat, Nico [2 ]
Horneff, Gerd [2 ]
Brik, Riva [2 ]
McCann, Liza [2 ]
Ozdogan, Huri [2 ]
Rutkowska-Sak, Lidia [2 ]
Schneider, Rayfel [1 ]
Berkun, Yackov [2 ]
Calvo, Inmaculada [2 ]
Erguven, Muferet [2 ]
Goffin, Laurence [2 ]
Hofer, Michael [2 ]
Kallinich, Tilmann [2 ]
Lheritier, Karine [4 ]
Abrams, Ken [5 ]
Stancati, Andrea [4 ]
Lovell, D. J. [6 ]
Martini, Alberto [2 ]
机构：
[1] Pediat Rheumatol Collaborat Study Grp PRCSG, Cincinnati, OH USA
[2] Paediat Rheumatol Int Trials Org PRINTO, Ist Giannina Gaslini, Genoa, Italy
[3] Necker Enfants Malades Hosp, Paris, France
[4] Novartis Pharma AG, Basel, Switzerland
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Cincinnati Childrens Hosp, Cincinnati, OH USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
759
引用
收藏
页码：S326 / S327
页数：2
相关论文
共 50 条
  • [31] EVALUATION OF EFFICACY AND SAFETY OF CANAKINUMAB IN JAPANESE PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN PHASE III CLINICAL TRIAL, COMPOSED PREDOMINANTLY OF PATIENTS WITH PRIOR USE OF TOCILIZUMAB
    Takei, S.
    Hara, R.
    Umebayashi, H.
    Iwata, N.
    Imagawa, T.
    Shimizu, M.
    Tomiita, M.
    Seko, N.
    Kitawaki, T.
    Wang, G.
    Yokota, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 499 - 500
  • [32] PHASE II TRIAL WITH CANAKINUMAB (ACZ885) TO EVALUATE SAFETY AND PRELIMINARY EFFICACY IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
    Ruperto, N.
    Quartier, P.
    Wulffraat, N.
    Woo, P.
    Loy, A.
    Mouy, A.
    Bader-Meunier, B.
    Prakken, B.
    Noseda, E.
    Belleli, R.
    Lecot, J.
    Rordorf, C.
    Martini, A.
    [J]. ACTA PAEDIATRICA, 2009, 98 : 223 - 224
  • [33] Safety and efficacy of oral ITF2357 in patients with active systemic onset juvenile idiopathic arthritis
    Vojinovic, Jelena
    Dinarello, Charles A.
    Furlan, Antonio
    Damjanov, Nemanja
    D'urzo, Carmine
    Oldoni, Tiziano
    [J]. CYTOKINE, 2009, 48 (1-2) : 93 - 94
  • [34] EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY
    Ruperto, Nicolino
    Spindler, Alberto
    Pacheco Tena, Cesar Francisco
    Louw, Ingrid
    Vega Cornejo, Gabriel
    Kingsbury, Daniel
    Clark, Michael
    Bensley, Karen
    Li Xiaoming
    Brunner, Hermine
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 966 - 966
  • [35] EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY
    Spindler, Alberto
    Ruperto, Nicola
    Pacheco Tena, Cesar Francisco
    Louw, Ingrid
    Vega-Cornejo, Gabriel
    Kingsbury, Daniel
    Clark, Michael
    Bensley, Karen
    Li, Xiaoming
    Brunner, Hermine
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S11 - S11
  • [36] Marked Improvement In Patient Reported Outcomes Of Children With Active Systemic Juvenile Idiopathic Arthritis With Canakinumab Treatment - Results Of The Phase III Program
    Schneider, Rayfel
    Brunner, Hermine I.
    Ruperto, Nicolino
    Wulffraat, Nico
    Quartier, Pierre
    Brik, Riva
    McCann, Liza
    Foster, Helen E.
    Frosch, Michael
    Gerloni, Valeria
    Harel, Liora
    Len, Claudio
    Houghton, Kristin
    Joos, Rik
    Abrams, Ken
    Lheritier, Karine
    Kessabi, Sophia
    Martini, Alberto
    Lovell, Daniel J.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S111 - S112
  • [37] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS: DATA FROM A PHASE 3 TRIAL
    De Benedetti, F.
    Ruperto, N.
    Zuber, Z.
    Keane, C.
    Harari, O.
    Kenwright, A.
    Cuttica, R.
    Keltsev, V.
    Xavier, R.
    Calvo, I.
    Nikishina, I.
    Rubio-Perez, N.
    Alekseeva, E.
    Chasnyk, V.
    Chavez, J.
    Horneff, G.
    Opoka-Winiarska, V.
    Quartier, P.
    Silva, C.
    Silverman, E.
    Spindler, A.
    Martini, A.
    Lovell, D.
    Brunner, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 70 - 70
  • [38] Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD AND TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
    De Benedetti, Fabrizio
    Anton, Jordi
    Ben-Chetrit, Eldad
    Calvo, Inmaculada
    Frenkel, Joost
    Gattorno, Marco
    Hoffman, Hal M.
    Kasapcopur, Ozgur
    Kone-Paut, Isabelle
    Lachmann, Helen
    Moutschen, Michel
    Ozen, Seza
    Quartier, Pierre
    Simon, Anna
    Zeft, Andrew
    Lheritier, Karine
    Speziale, Antonio
    Junge, Guido
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [39] Efficacy and Safety of Canakinumab in Patients with Periodic Fever Syndromes (Colchicine-Resistant FMF, HIDS/MKD and TRAPS): Results from a Phase 3, Pivotal, Umbrella Trial
    De Benedetti, Fabrizio
    Anton, Jordi
    Ben-Chetrit, Eldad
    Calvo, Inmaculada
    Frenkel, Joost
    Gattorno, Marco
    Hoffman, Hal M.
    Kasapcopur, Ozgur
    Kone-Paut, Isabelle
    Lachmann, Helen
    Moutschen, Michel
    Ozen, Seza
    Quartier, Pierre
    Simon, Anna
    Zeft, Andrew
    Lheritier, Karine
    Speziale, Antonio
    Junge, Guido
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69 : 22 - 23
  • [40] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2019, 58
12345